ArticleJournal of immunology research2018

OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.

Kristien Van Belle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.